Back

Endogenous glucocorticoids are required for normal macrophage activation and gastric Helicobacter pylori immunity

Khadka, S.; Dziadowicz, S. A.; Xu, X.; Lei, W.; Hu, G.; Busada, J. T.

2024-01-15 immunology
10.1101/2024.01.14.575574 bioRxiv
Show abstract

Glucocorticoids are steroid hormones well-known for their potent anti-inflammatory effects. However, their immunomodulatory properties are multifaceted. Increasing evidence suggests that glucocorticoid signaling promotes effective immunity and that disruption of glucocorticoid signaling impairs immune function. In this study, we conditionally deleted the glucocorticoid receptor (GR) in the myeloid lineage using the LysM-Cre driver (myGRKO). We examined the impact on macrophage activation and gastric immune responses to Helicobacter pylori, the best-known risk factor of gastric cancer. Our results indicate that compared to WT, GRKO macrophages exhibited higher expression of proinflammatory genes in steroid-free conditions. However, when challenged in vivo, GRKO macrophages exhibited aberrant chromatin landscapes and impaired proinflammatory gene expression profiles. Moreover, gastric colonization with Helicobacter revealed impaired gastric immune responses and reduced T cell recruitment in myGRKO mice. As a result, myGRKO mice were protected from atrophic gastritis and pyloric metaplasia development. These results demonstrate a dual role for glucocorticoid signaling in preparing macrophages to respond to bacterial infection but limiting their pathogenic activation. In addition, our results support that macrophages are critical for gastric anti- Helicobacter immunity. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=159 SRC="FIGDIR/small/575574v1_ufig1.gif" ALT="Figure 1"> View larger version (34K): org.highwire.dtl.DTLVardef@7d5281org.highwire.dtl.DTLVardef@1b39ca2org.highwire.dtl.DTLVardef@f081caorg.highwire.dtl.DTLVardef@1d9215d_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

1
Cell Communication and Signaling
35 papers in training set
Top 0.1%
12.7%
2
Frontiers in Immunology
586 papers in training set
Top 0.5%
10.3%
3
Gut Microbes
70 papers in training set
Top 0.1%
6.9%
4
eLife
5422 papers in training set
Top 16%
4.9%
5
Cell Reports
1338 papers in training set
Top 11%
4.4%
6
Frontiers in Cellular and Infection Microbiology
98 papers in training set
Top 1%
3.1%
7
Gastroenterology
40 papers in training set
Top 0.7%
2.4%
8
Cellular and Molecular Gastroenterology and Hepatology
41 papers in training set
Top 0.3%
2.1%
9
European Journal of Immunology
57 papers in training set
Top 0.2%
2.1%
10
International Journal of Molecular Sciences
453 papers in training set
Top 6%
1.8%
50% of probability mass above
11
The Journal of Nutritional Biochemistry
13 papers in training set
Top 0.2%
1.7%
12
iScience
1063 papers in training set
Top 14%
1.7%
13
Scientific Reports
3102 papers in training set
Top 57%
1.7%
14
Neuroscience & Biobehavioral Reviews
43 papers in training set
Top 0.4%
1.7%
15
Frontiers in Oncology
95 papers in training set
Top 2%
1.5%
16
Science Signaling
55 papers in training set
Top 0.1%
1.5%
17
EMBO reports
136 papers in training set
Top 3%
1.5%
18
Disease Models & Mechanisms
119 papers in training set
Top 1%
1.4%
19
Life Science Alliance
263 papers in training set
Top 0.5%
1.4%
20
Journal of Leukocyte Biology
40 papers in training set
Top 0.3%
1.4%
21
Immunology
29 papers in training set
Top 0.6%
1.2%
22
PLOS ONE
4510 papers in training set
Top 61%
1.1%
23
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 7%
1.0%
24
The Journal of Immunology
146 papers in training set
Top 1%
1.0%
25
Brain, Behavior, and Immunity
105 papers in training set
Top 2%
1.0%
26
PLOS Biology
408 papers in training set
Top 16%
0.9%
27
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 42%
0.8%
28
Mucosal Immunology
42 papers in training set
Top 0.3%
0.8%
29
Open Biology
95 papers in training set
Top 2%
0.8%
30
The FASEB Journal
175 papers in training set
Top 3%
0.8%